
Bioorganic and Medicinal Chemistry p. 1365 - 1377 (1996)
Update date:2022-08-03
Topics:
Komai, Tomoaki
Higashida, Susumu
Sakurai, Mitsuya
Nitta, Tamayo
Kasuya, Atsushi
Miyamaoto, Shuichi
Yagi, Ryuichi
Ozawa, Yuji
Handa, Hiroshi
Mohri, Hiroshi
Yasuoka, Akira
Oka, Shinichi
Nishigaki, Takashi
Kimura, Satoshi
Shimada, Kaoru
Yabe, Yuichiro
Systematic replacement in the 3- or 4-position of the pyrrolidine ring at P1' proline was carried out. Compound 26, which has a Cl atom in the 4(S)-position was the most active among inhibitors substituted with other halogen atoms or other substituents. Furthermore, the replacement of the Z group in compound 26 with five- or six-membered fused aromatic heterocycle carbonyl groups produced more potent inhibitors. 7-Methoxybenzofuran-2-carbonyl derivative (44) was the best of these and showed K(i) = 4.5 nM against HIV PR and IC90s 0.58 μM and 0.06 μM in chronic and acute infections, respectively. These results suggest that the combination of the 4(S)-Cl atom and fused bicyclic heterocycles may be effective in improving their cellular penetration.
View MoreTianjin Anda North Industrial & Business Co.Ltd.
Contact:86-22-24999306
Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
Xi'an North Information Industry Co., Ltd. Weilv Chemical Department
Contact:+86-29-88156413
Address:Jixiang Road 99 Xi'an Shaanxi Province
Shanghai Hanshare Industry Co.,Ltd.
Contact:86 21 20960688
Address:RM902-903,Building E, Wanda Plaza,No.26,Zhoukang Road, Pudong District, Shanghai, China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Beijing Mesochem Technology Co.,LTD
website:http://www.mesochem.com
Contact:0086-10-57862036
Address:2301, Floor 23, Building 9 Lippo Plaza, Yard 8 Ronghua Middle Road, ETDZ, Beijing, China
Doi:10.1021/acs.inorgchem.1c01274
(2021)Doi:10.1155/2019/2385064
(2019)Doi:10.1016/0040-4039(95)00600-H
(1995)Doi:10.1021/om990050g
(1999)Doi:10.1021/ol048322l
(2004)Doi:10.1016/S0040-4039(98)02687-2
(1999)